# STMicroelectronics N.V.: financial statements, quarterly

STM · NYSE · CIK 932787 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stm.md) · [Financials](/companies/stm/financials.md) · [Filings](/companies/stm/filings.md) · [Insiders](/companies/stm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stm/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2019-09-30) |
| --- | --- | ---: |
| Income tax | $m | [20.0](/filings/0001564590-20-006795.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.0](/filings/0001193125-18-067609.md) | [1.8](/filings/0001193125-19-057507.md) | [1.6](/filings/0001193125-19-057507.md) | [1.8](/filings/0001193125-19-057507.md) | [2.3](/filings/0001564590-20-006795.md) | [2.6](/filings/0001564590-21-008102.md) | [3.0](/filings/0001564590-22-006712.md) | [3.2](/filings/0001564590-23-002312.md) | [3.3](/filings/0001628280-24-006353.md) | [3.2](/filings/0000932787-25-000006.md) | [2.3](/filings/0000932787-26-000009.md) | [2.8](/filings/0000932787-26-000009.md) |
| Current assets | $bn | [5.1](/filings/0001193125-16-506926.md) | [4.7](/filings/0001193125-17-069977.md) | [4.4](/filings/0001193125-18-067609.md) | [5.1](/filings/0001193125-19-057507.md) | [5.9](/filings/0001564590-20-006795.md) | [6.3](/filings/0001564590-21-008102.md) | [7.6](/filings/0001564590-22-006712.md) | [7.8](/filings/0001564590-23-002312.md) | [9.8](/filings/0001628280-24-006353.md) | [11.8](/filings/0000932787-25-000006.md) | [11.7](/filings/0000932787-26-000009.md) | [11.3](/filings/0000932787-26-000009.md) |
| Total assets | $bn | [9.0](/filings/0001193125-16-506926.md) | [8.2](/filings/0001193125-17-069977.md) | [8.0](/filings/0001193125-18-067609.md) | [9.7](/filings/0001193125-19-057507.md) | [10.9](/filings/0001564590-20-006795.md) | [11.9](/filings/0001564590-21-008102.md) | [14.5](/filings/0001564590-22-006712.md) | [15.5](/filings/0001564590-23-002312.md) | [20.0](/filings/0001628280-24-006353.md) | [24.5](/filings/0000932787-25-000006.md) | [24.7](/filings/0000932787-26-000009.md) | [24.8](/filings/0000932787-26-000009.md) |
| Current liabilities | $bn | [1.8](/filings/0001193125-16-506926.md) | [1.6](/filings/0001193125-17-069977.md) | [1.6](/filings/0001193125-18-067609.md) | [2.0](/filings/0001193125-19-057507.md) | [2.1](/filings/0001564590-20-006795.md) | [2.1](/filings/0001564590-21-008102.md) | [3.1](/filings/0001564590-22-006712.md) | [2.9](/filings/0001564590-23-002312.md) | [3.8](/filings/0001628280-24-006353.md) | [3.7](/filings/0000932787-25-000006.md) | [3.8](/filings/0000932787-26-000009.md) | [3.4](/filings/0000932787-26-000009.md) |
| Total liabilities | $bn | [3.9](/filings/0001193125-16-506926.md) | [3.5](/filings/0001193125-17-069977.md) | [3.4](/filings/0001193125-18-067609.md) | [4.2](/filings/0001193125-19-057507.md) | [4.4](/filings/0001564590-20-006795.md) | [4.8](/filings/0001564590-21-008102.md) | [5.9](/filings/0001564590-22-006712.md) | [6.3](/filings/0001564590-23-002312.md) | [7.2](/filings/0001628280-24-006353.md) | [7.6](/filings/0000932787-25-000006.md) | [7.1](/filings/0000932787-26-000009.md) | [6.6](/filings/0000932787-26-000009.md) |
| Long-term debt | $bn | [1.6](/filings/0001193125-16-506926.md) | [1.4](/filings/0001193125-17-069977.md) | [1.3](/filings/0001193125-18-067609.md) | [1.6](/filings/0001193125-19-057507.md) | [1.8](/filings/0001564590-20-006795.md) | [1.9](/filings/0001564590-21-008102.md) | [1.8](/filings/0001564590-22-006712.md) | [2.4](/filings/0001564590-23-002312.md) | [2.5](/filings/0001628280-24-006353.md) | [2.7](/filings/0000932787-25-000006.md) | [2.0](/filings/0000932787-26-000009.md) | [1.8](/filings/0000932787-26-000009.md) |
| Current portion of debt | $bn | [0.2](/filings/0001193125-16-506926.md) | [0.2](/filings/0001193125-17-069977.md) | [0.1](/filings/0001193125-18-067609.md) | [0.1](/filings/0001193125-19-057507.md) | [0.1](/filings/0001564590-20-006795.md) | [0.2](/filings/0001564590-21-008102.md) | [0.8](/filings/0001564590-22-006712.md) | [0.1](/filings/0001564590-23-002312.md) | [0.2](/filings/0001628280-24-006353.md) | [0.2](/filings/0000932787-25-000006.md) | [1.0](/filings/0000932787-26-000009.md) | [0.3](/filings/0000932787-26-000009.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.0](/filings/0001193125-16-506926.md) | [4.6](/filings/0001193125-17-069977.md) | [4.5](/filings/0001193125-18-067609.md) | [5.4](/filings/0001193125-19-057507.md) | [6.4](/filings/0001564590-20-006795.md) | [7.0](/filings/0001564590-21-008102.md) | [8.4](/filings/0001564590-22-006712.md) | [9.2](/filings/0001564590-23-002312.md) | [12.7](/filings/0001628280-24-006353.md) | [16.7](/filings/0000932787-25-000006.md) | [17.4](/filings/0000932787-26-000009.md) | [17.8](/filings/0000932787-26-000009.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2022-09-30) | Q4 FY2022 (2022-12-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | period not labelled (2025-06-30) | period not labelled (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Dividends paid | $m | [54.0](/filings/0000932787-25-000006.md) | [48.0](/filings/0000932787-25-000006.md) | [55.0](/filings/0000932787-26-000009.md) | [54.0](/filings/0000932787-26-000009.md) | [54.0](/filings/0000932787-25-000006.md) | [54.0](/filings/0000932787-25-000006.md) | [81.0](/filings/0000932787-26-000009.md) | [81.0](/filings/0000932787-26-000009.md) | [72.0](/filings/0000932787-26-000009.md) | [81.0](/filings/0000932787-26-000009.md) | [80.0](/filings/0000932787-26-000009.md) | [71.0](/filings/0000932787-26-000009.md) |

- Dividends paid: us-gaap:PaymentsOfDividends

Shares outstanding: 888,768,152 at 2025-12-31, from the cover of the [20-F filed 2026-02-26](/filings/0000932787-26-000009.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.
